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Medicine, Tokyo, Japan.BACKGROUND Ventricular ﬁbrillation may be caused by premature
ventricular contractions (PVCs) whose coupling intervals areo300
ms, a characteristic of the short-coupled variant of torsades de
pointes (scTdP).
OBJECTIVE The purpose of this study was to analyze the underlying
cardiac ryanodine receptor (RyR2) variants in patients with scTdP.
METHODS Seven patients with scTdP (mean age 34 ± 12 years; 4
men and 3 women) were enrolled in this study. The RyR2 gene was
screened by targeted gene sequencing methods; variant minor
allele frequency was conﬁrmed in 3 databases; and the pathoge-
nicity was investigated in silico analysis using multiple tools. The
activity of wild-type and mutant RyR2 channels was evaluated by
monitoring Ca2þ signals of HEK293 cells with a [3H]ryanodine
binding assay.
RESULTS The mean coupling interval of PVCs was 282 ± 13 ms. The
12-lead electrocardiogram had no speciﬁc ﬁndings except PVCs with
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All rights reserved.novel RyR2 variants and 1 polymorphism, all located in the
cytoplasmic region. p.Ser4938Phe was not detected in 3 databases,
and in silico analysis indicated its pathogenicity. In functional
analysis, p.Ser4938Phe demonstrated loss of function and impaired
RyR2 channel Ca2þ release, while 2 other variants, p.Val1024Ile and
p.Ala2673Val, had mild gain-of-function effects but were similar to
the polymorphism p.Asn1551Ser.
CONCLUSION We identiﬁed an RyR2 variant associated with reduced
Ca2þ release and short-coupled torsades de pointes ventricular
arrhythmia. The mechanisms of arrhythmogenesis remain unclear.
KEYWORDS Torsades de pointes; Catecholaminergic polymorphic
ventricular tachycardia; Idiopathic ventricular ﬁbrillation; RyR2; Long QT
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Elsevier Inc. on behalf of Heart Rhythm Society. This is an open access
article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). All rights
reserved.Background
During the eighties and nineties, several case reports
described a different form of polymorphic ventricular
tachycardia (VT) triggered by premature ventricular
contractions (PVCs) with an extremely short-coupling
interval.1–3 This speciﬁc form of ventricular arrhythmia
was named the short-coupled variant of torsades de pointes
(scTdP) and now constitutes another type of idiopathic
ventricular ﬁbrillation (IVF) without structural heart
disease.4behalf of Heart Rhythm Society. This is an open access article under the CC
http://dx.doi.org/10.1016/j.hrthm.2016.10.015
99Fujii et al RyR2 Variants in Short-Coupled Variant of Torsades de PointesThe underlying molecular pathogenesis deﬁning the
arrhythmogenicity of this disorder has been partially
elucidated. In 2011, we reported a case with a heterozygous
KCNE5 Y81H variant (case 5 in Table 1)5 after the
diagnosis of scTdP 2 years after receiving an implantable
cardioverter-deﬁbrillator (ICD) because it recorded the
initiation of fatal arrhythmias. Functional assays revealed
that the variant caused a gain-of-function effect on recon-
stituted transient outward currents when coexpressed with
Kv4.3 and Kv channel interacting protein (KChIP2).5 After
treatment with oral verapamil, the patient remained free
from ventricular ﬁbrillation (VF) recurrence. Then 2 years
later, Wilde’s group6 reported a mutation of DPP6 in an
IVF family with extremely short-coupling interval PVCs
and demonstrated that DPP6 plays an important role in IVF
arrhythmogenicity by affecting transient outward currents in
Purkinje ﬁbers. These studies suggest that scTdP may be
associated with Purkinje network and intracellular Ca2þ
handling.
scTdP is electrocardiographically deﬁned by (1) PVCs
with a short-coupling interval, (2) relatively narrow
QRS durations, and (3) normal corrected QT intervals.7
One protein that helps maintain healthy intracellular
Ca2þ dynamics is the cardiac ryanodine receptor (RyR2),
encoded by the RyR2 gene, which is Ca2þ-releasing
channel expressed at sarcoplasmic reticulum membranes.8
Therefore, RyR2 malfunction may be related to scTdP-
type arrhythmias. RyR2 mutations are generally known to
cause catecholaminergic polymorphic ventricular tachy-
cardia (CPVT),9 which is also related to abnormal
intracellular Ca2þ handling but recently an RyR2 muta-
tion (p.His29Asp) was reported to be associated with
scTdP.10
In the present study, we extensively examined the
fashion of TdP or short-coupled PVC initiation in our
IVF cohort and identiﬁed 7 cases that fulﬁlled the scTdP
criteria (as listed in the Methods section) and then
sequenced RyR2. We then conducted the functional anal-
ysis of wild-type (WT) or patient RyR2 variants in the
HEK293 cells to determine whether the intracellular Ca2þ
dynamics of mutant RyR2 channels were associated with
scTdP arrhythmogenicity.Methods
Patients
Seven patients demonstrating PVCs with a short-coupling
interval (≤300 ms) were enrolled in this study (Table 1).
Case 7 presented multiple VF episodes induced by PVCs
with a short-coupling interval (230 ms) after ICD implan-
tation while PVCs were not recorded on a regular 12-lead
electrocardiogram (ECG). All patients displayed arrhyth-
mic syncope, documented VF, or TdP, where TdP was
deﬁned as a polymorphic VT of ≥3 beats with a QRS axis
that revolved around the baseline (the latter deﬁnition was
not applied when only intracardiac tachycardia ECGs were
available).Clinical scTdP data and genetic analysis
Detailed methods are available in the Online
Supplemental Material. Genetic analysis was performed
after obtaining written informed consent in accordance
with the study protocol approved by the Shiga University
of Medical Science Review Board. Genomic DNA was
extracted from peripheral blood lymphocytes. The RyR2
gene underwent targeted gene sequencing method using
the TruSeq Custom Amplicon kit (Illumina, San Diego,
CA) and the MiSeq System (Illumina). Detected variants
were conﬁrmed using Sanger methods. We veriﬁed minor
allele frequency (MAF) of the variants in 3 databases
including Japanese Human Genetic Variation Database
(http://www.genome.med.kyoto-u.ac.jp/SnpDB/index.html),
ExAC Database (http://exac.broadinstitute.org/), and 1000
Genomes Project (http://browser.1000genomes.org/index.
html), and we considered variants to be mutations when
MAF is o0.005.RyR2 functional analysis
RyR2 complementary D NA was obtained from mouse
ventricles, and then stable inducible HEK293 cells were
generated using the Flp-In T-REx system (Invitrogen,
Carlsbad, CA). Cytoplasmic and endoplasmic reticulum
(ER) luminal Ca2þ signals were monitored with ﬂuo-4 and
R-CEPIA1er, respectively. [3H]Ryanodine binding assays
were carried out with microsomes isolated from HEK293
cells. Detailed methods are available in the Online
Supplemental Material.Statistical analysis
Data are expressed as means ± SD or SEM with a speciﬁc
comment. Statistical analysis was performed using the
unpaired Student t test, and the P value of o.05 was
considered signiﬁcant.Results
Clinical characteristics of scTdP
Table 1 summarizes the clinical characteristics of 7 cases
(mean age of 34 ± 12 years; 4 men and 3 women). None
of the patients had a family history of sudden cardiac
death. Figure 1 shows representative ECGs recorded from
the ﬁrst 6 cases. PVC coupling intervals were short with
a mean of 282 ± 13 ms. QRS intervals were prolonged,
and their average width was 138 ± 16 ms. PVC
morphology indicated left bundle blanch block with left
axis deviation in 5 cases. In the remaining 1 case, this
could not be determined because a 12-lead ECG was not
available at the time of appearance of PVCs. The average
corrected QT interval was normal (422 ± 21 ms), and
Brugada-like ST-segment or J-point elevations were not
observed at the onset of TdP. Echocardiography revealed
no structural heart disease, and the cardiac function was
judged to be normal (ejection fraction 450%; mean 62%
Table 1 Clinical characteristics of scTdP cases
Characteristic Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
Age at onset (y) 30 48 24 38 47 41 13
Sex M F F M F M M
Family history of SCD No No No No No No No
Symptoms VF, syncope VF, syncope VF, syncope VF, syncope VF, syncope VF, syncope VF, syncope
Conditions at the ﬁrst onset During talking at night After waking in the
morning
After lunch During
dinner
During working in
the daytime
In the room at night After exercise
PVC morphology
PVC origin LBBB, LAD LBBB, LAD LBBB, LAD LBBB, LAD NA LBBB, LAD NA
PVC coupling (ms) 300 290 280 280 260 280 NA
PVC duration (ms) 130 130 130 130 140 170 NA
ECG ﬁndings
RR interval (ms) 857 800 800 909 811 937 720
PR interval (ms) 162 146 160 170 164 170 160
QRS interval (ms) 94 94 72 98 90 106 80
QRS axis Normal Normal Normal Normal Normal Normal Normal
QTc duration (ms) 440 431 425 397 455 408 401
J wave No No No No No Yes* No
Pilsicainide test Negative Negative Negative Negative Negative Negative Negative
Electrophysiology study
VF induced by ventricular
stimuli
Induced VF by 2
extrastimuli from the
apex of the right
ventricle
Not induced Not induced Not induced Induced VF by 2
extrastimuli
from the apex of the
right ventricle
Induced VF by 2 extra
stimuli
from the apex of the
right ventricle
Not induced
Documented Purkinje origin Yes NA Yes Yes NA NA NA
Ablation Yes No Yes Yes No No No
Ejection fraction (%) 61 57 54 64 63 75 Normal
Treadmill exercise test NA NA Not induced VT NA NA NA Not induced VTs
Coronary angiography NA No CAD No CAD NA No CAD No CAD No CAD
Follow-up after the onset
Follow-up period (mo) 69 90 25 37 80 68 7
Implanted ICD Yes Yes Yes Yes Yes Yes Yes
ICD therapy Appropriate shock No No No Appropriate shock Appropriate shock Appropriate
shock
Present medication No drug No drug Verapamil, 120
mg
No drug Verapamil, 120 mg Bepridil, 100 mg Verapamil, 120
mg
CAD ¼ coronary artery disease; ECG ¼ electrocardiographic; F ¼ female; ICD ¼ implantable cardioverter-deﬁbrillator; LAD ¼ left axis deviation; LBBB ¼ left bundle branch block; M ¼ male; NA ¼ not available;
PVC ¼ premature ventricular contraction; QTc ¼ corrected QT; SCD ¼ sudden cardiac death; scTdP ¼ short-coupled variant of torsades de pointes; VF ¼ ventricular ﬁbrillation; VT ¼ ventricular tachycardia.
*J wave appeared regardless the onset of ventricular arrhythmias.
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Figure 1 PVC in 12-lead ECG for each scTdP case. PVCs with left bundle branch block and left axis deviation were representative in 5 cases.
Case 5 had ECG monitoring during a TdP episode on admission. ECG ¼ electrocardiogram; PVC ¼ premature ventricular contraction;
TdP ¼ torsades de pointes.
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3 and 7) did not have VT during exercise. Pilsicainide
tests failed to provoke a typical Brugada ECG (coved
type) in all cases displaying negative late potentials.
T-wave alternans was positive in case 1, but not in case
5. Coronary angiography failed to reveal coronary disease
in 5 cases. Electrophysiological investigations with the
programmed ventricular stimulation (up to 3 stimuli) at
the apex and outﬂow tract of the right ventricle were
performed in all patients. Nonsustained VT was induced
in 2 patients, and sustained VT was induced in 1 patient.
VT was not induced in the remaining 4 cases. Frequent
PVCs were present in cases 1, 3, and 4, and catheter
ablation was performed.Novel RyR2 mutations in scTdP
As shown in Figure 2A, genetic analysis revealed
missense variants in 3 cases (cases 3, 6, and 7) and a
polymorphism in 1 case (case 1). The p.Val1024Ile
(V1024I, case 3) and p.Ala2673Val (A2673V, case 6)
variants were located in the N-terminal cytoplasmic
region and involved a guanine to adenine substitution
in exon 27 (c.3070G4A) and a cytosine to thymine in
exon 53 (c.8018C4T). p.Ser4938Phe (S4938F, case 7)
was located in the C-terminal cytoplasmic region where a
cysteine was changed to thymine in the last exon, exon
105 (c.14813C4T). Clinical information including fam-
ilial analysis is shown in Figures 2B–E and identiﬁed 1
asymptomatic carrier and 3 noncarriers. Although
A2673V and S4938F were not detected in 3 databases
listed in the Methods section, V1024I was reported inthe Human Genetic Variation Browser with an MAF
of 0.0035. As shown in Table 2, in silico analysis
using multiple tools suggested S4938F pathogenicity,
while pathogenicity predictions were nonconclusive for
V1024I and A2673V. The p.Asn1551Ser (c.4652A4G,
N1551S) variant was a common variant in East Asians
and listed as a polymorphism detected in 41% Japanese
controls.Ca2þ homeostasis in HEK cells expressing WT and
mutant RyR2s
To determine the Ca2þ releasing properties of scTdP-related
RyR2 variants, we generated stable inducible HEK293
cell lines expressing WT and mutant murine RyR2s and
monitored cytoplasmic Ca2þ signals with ﬂuo-4 (Figure 3).
When WT RyR2 was expressed in HEK293 cells, they
showed spontaneous Ca2þ oscillations as reported11 (Online
Supplemental Movie 1). Among scTdP-related variants,
N1551S, V1024I, and A2673V demonstrated similar proﬁles
and exhibited only slightly modiﬁed Ca2þ oscillations com-
pared with WT. The oscillation frequency was slightly but
signiﬁcantly higher in V1024I cells (~1.5 fold) than
in WT cells (Online Supplemental Movie 2), whereas
oscillation amplitudes were moderately and signiﬁcantly
decreased in N1551S and A2673V cells (Figures 3A and
B). These results suggest that the 3 variants may have slightly
increased Ca2þ releasing activity. In contrast, S4938F cells
exhibited only occasional tiny ﬂuctuations without oscillations
(Online Supplemental Movie 3). The addition of caffeine—a
known RyR enhancer—caused massive Ca2þ release so that
S4938F channels appeared functional but with low activity.
Figure 2 Topology of RyR2 variants (panel A) and clinical features in patients with p.Ser4938Phe (panels B–E). A: The topology of cardiac ryanodine
receptor and locations of RyR2 mutations. B and C: H29D is a reported mutation by Cheung et al.10 Ventricular tachycardia failed to appear not only at rest but
also during exercise. D: Ventricular tachycardia initiated by premature ventricular contraction with an extremely short-coupling interval (230 ms) was recorded
in the implantable cardioverter-deﬁbrillator. E: Family history and genetic analysis. scTdP ¼ short-coupled variant of torsades de pointes; SR ¼ sinus rhythm;
WT ¼ wild type.
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CEPIA1er, a genetically encoded ER Ca2þ sensor pro-
tein12,13 in the absence and presence of tetracaine. As
indicated in Figure 4A, HEK cells expressing WT RyR2
showed periodic decreases in R-CEPIA1er signals in
normal Krebs solution, reﬂecting ER Ca2þ release. Before
each Ca2þ release, the R-CEPIA1er signal reached at a
maximum (upper threshold) and then rapidly decreased to
reach a minimum (nadir), and gradually increased again
toward the maximal. The upper threshold and nadir ERlevels attained correspond to the Ca2þ release initiation
and termination levels, respectively. Both upper threshold
and nadir levels were slightly reduced in N1551S, V1024I,
and A2673V cells compared with WT cells. In contrast,
S4938F cells showed signiﬁcantly higher ER Ca2þ signals
without any oscillations. These results indicate that S4938F
channel activity is substantially lowered compared with
WT channel activity, while N1551S, V1024I, and A2673V
channel activity may be slightly increased. These results
were supported with the addition of 1 mM tetracaine, a
Table 2 Characteristics of RyR2 mutations
Characteristic Case 1 Case 3 Case 6 Case 7
Nucleotide change c.4652A4G c.3070G4A c.8018C4T c.14813C4T
Amino acid change p.Asn1551Ser p.Val1024Ile p.Ala2673Val p.Ser4938Phe
Location Cytosol Cytosol Cytosol Cytosol
Allele frequency in normal controls
1000 Genomes Project* None None None None
ExAC Browser† 0.0003 None None None
Human Genetic Variation Browser‡ 0.005 0.0035 None None
In silico data
MutationAssessor§ Low Neutral Medium Medium
SIFT║ Tolerated Tolerated Damaging Damaging
SNPs&GO¶ Disease Disease Neutral Disease
MutationTaster# Disease causing Disease causing Disease causing Disease causing
PolyPhen-2** Possibly damaging Probably damaging Probably damaging Possibly damaging
PROVEAN†† Neutral Neutral Deleterious Deleterious
CADD‡‡ 23.9 15.75 34 24.7
*http://browser.1000genomes.org.
†http://exac.broadinstitute.org/.
‡http://www.genome.med.kyoto-u.ac.jp/SnpDB/.
§http://mutationassessor.org.
║http://sift.jcvi.org.
¶http://snps-and-go.biocomp.unibo.it/snps-and-go.
#http://www.mutationtaster.org.
**http://genetics.bwh.harvard.edu/pph2.
††http://provean.jcvi.org/index.php.
‡‡http://cadd.gs.washington.edu.
Figure 3 Cytoplasmic Ca2þ signals in HEK293 cells expressing WT and mutant RyR2s. A: Representative ﬂuo-4 signals obtained in normal Krebs solution
after the addition of 30 mM caffeine. Fluorescence signal values are normalized to Fmax (see Online Supplemental Methods). The vertical bar in the S4938F inset
indicates 0.02F/Fmax. B: Average oscillation frequency in WT and mutant cells. C: Average oscillation amplitude (ΔF/Fmax) in WT and mutant cells. Data are
presented as mean ± SEM. n ¼ 31–69. ***P o .001 vs WT. WT ¼ wild type.
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Figure 4 ER Ca2þ signals in HEK293 cells expressing WT and mutant RyR2s. A: Representative R-CEPIA1er signals obtained in normal Krebs solution
followed by sequential treatment with 1 mM tetracaine, 30 mM caffeine, and high Ca2þ Krebs solution with ionomycin. ER Ca2þ signals were expressed as
normalized values, (F − Fmin)/(Fmax − Fmin) (see Online Supplemental Methods).B: ER upper threshold and nadir Ca2þ levels in normal Krebs solution. Data are
presented as mean ± SEM. n ¼ 57–112. ***P o .001 vs WT upper threshold. ###P o .001 vs WT nadir level. C: ER Ca2þ levels in the presence of 1 mM
tetracaine. *P o .05 vs WT. ER ¼ endoplasmic reticulum; WT ¼ wild type.
Heart Rhythm, Vol 14, No 1, January 2017104potent RyR2 inhibitor. R-CEPIA1er ER signals clearly
increased in WT, N1551S, V1024I, and A2673V cells after
treatment, whereas S4938F cell ER Ca level remained
unaffected (Figures 4A and B).
Ca2þ-dependent [3H]ryanodine binding activity
The properties of Ca2þ-induced Ca2þ release (CICR) acti-
vity were evaluated by Ca2þ-dependent [3H]ryanodine bind-
ing.12 WT channels exhibited biphasic Ca2þ dependence
(Figure 5A). Three variants (V1024I, N1551S, and A2673V)
showed slight increases in [3H]ryanodine binding, whereas it
was greatly reduced by S4938F. The biphasic properties of
CICR activity are explained by 3 parameters, that is, gain
constant (Amax) and dissociation constants for activating
Ca2þ (KA) and inactivating Ca
2þ (KI) (Figure 5B).
12 The
[3H]ryanodine binding data for the mutant channels were
ﬁtted to Equations (1)–(3) (see Online Supplemental
Methods) to obtain the 3 parameters (Figures 5C–E). Threevariants (V1024I, N1551S, and A2673V) slightly but
signiﬁcantly increased Amax with no alterations in KA or
KI. In contrast, S4938F halved Amax and doubled KA
compared with WT. S4938F exhibited no apparent Ca2þ-
dependent inactivation, resulting in a large KI value. Taken
altogether, these results suggest that the S4938F variant
greatly decreases the CICR activity, whereas the other 3
variants slightly increase it.Discussion
In the present study, we examined representative scTdP
cases in our patient cohort and their underlying genetics. We
conﬁrmed existing knowledge and provided novel insights
via the functional analysis of an scTdP variant causing the
loss of ER Ca2þ release.
TdPs often observed in long QT syndrome are initiated
by PVCs occurring on the downslope of T waves (R-on-
Figure 5 A: Ca2þ-dependent [3H]ryanodine binding to microsomes from HEK293 cells expressing WT and mutant RyR2 channels. B: Three parameters for
CICR (Amax, KA, and KI). CICR are expressed as A¼Amax  fA  1-fIð Þ (see Online Supplemental Methods). C–E: Calculated parameters for each mutant.
Although 3 variants (V1024I, N1551S, and A2673V) exhibited a slight increase in gain, S4938F showed decreased gain with reduced sensitivities to activating
and inactivating Ca2þ. *P o .05 (n ¼ 3–5). CICR ¼ Ca2þ-induced Ca2þ release; WT ¼ wild type.
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hardt et al4 reported 14 cases with TdP caused by PVCs
whose coupling intervals were extremely short. Their ECGs
displayed typical TdP, with an unusually short-coupling
interval during the ﬁrst TdP beat (always o300 ms). Most
cycle lengths just before the start of episodes did not show
short-long-short–coupling patterns, and episodes occurred
during regular sinus rhythm. Only 1 patient with scTdP
(case 6) presented J waves in the inferior leads, which were
of the slurred type and were transiently observed in leads III
and aVF throughout the clinical course. J waves appeared
despite the presence of VT or short-coupled PVCs and
disappeared with the onset of VF. J waves in this case may
not be a critical ﬁnding, but rather a sign of clinical or
genetic heterogeneity.
Thus, the ECG and clinical characteristics of scTdP are
normal except for the presence of PVCs with a short-
coupling interval. It is therefore often difﬁcult for us to
diagnose patients with scTdP after PVCs have disappeared.
Although the mechanisms underlying scTdP remain unclear,
the syndrome may have a genetic background in some cases,
since ~30% of cases have a family history of sudden death of
unknown etiology.4 A recent study10 revealed an RyR2missense mutation in an scTdP case without any CPVT
phenotypes.
The occurrence of PVCs during ventricular refractory
periods may be linked to abnormalities of action potential
duration during transmural repolarization. Although there
are no unique ECG ﬁndings in scTdP other than the
characteristics of PVCs, ion channel dysfunction may con-
tribute to their occurrence or altered Purkinje network
activity.6,7,15,16 According to our experimental data, the
intracellular Ca2þ dynamics can be associated with scTdP
arrhythmogenicity. A mutation in the cytoplasmic C termi-
nus, S4938F, produced RyR2 channels with severe loss of
function. Candidate RyR2 mutations in CPVT causing gain-
of-function RyR2 abnormalities17–20 have been reported,
while RyR2 p.Ala4860Gly reported by Priori et al21 demon-
strated loss of function similar to S4938F in our patient.22,23
Although it remains unknown how loss-of-function type of
RyR2 variants cause 2 phenotypes (CPVT and scTdP),24 as
schematically shown in Figure 6, the abnormal Ca2þ
dynamics in the cytosol and ER lumen may induce triggered
activity afterdepolarizations, especially via ER Ca over-
load,16 and nonfunctioning RyR2 mutant channels with loss
of function may cause early afterdepolarization but not
Figure 6 Mechanism of short-coupled variant of torsades de pointes with a loss-of-function RyR2 variant. RyR2 mutant channels with loss of function may
cause early afterdepolarization but not delayed afterdepolarization through the inhibition of Ca2þ-dependent Ca channel inactivation. Modiﬁed from Zhao et al.24
ATP ¼ adenosine triphosphate; NCX ¼ Naþ/Ca2þ exchanger; PLB ¼ phospholamban; SR ¼ sarcoplasmic reticulum.
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channel inactivation.24Study limitations
Our scTdP cohort was limited in size and therefore results
require conﬁrmation in a larger number of cases. We would
emphasize that 3 RyR2 variants with mild gain of function
are not pathogenic but “genetic noise” and are unlikely to
play a disease-causing role as their functional changes were
too mild to explain clinical phenotypes. Unlike CPVT,
bidirectional VT or frequent PVCs failed to appear during
exercise in this patient with scTdP with RyR2 loss of
function. The typical pattern of CPVT-associated arrhyth-
mias is a bidirectional VT with long PVC coupling interval
with mean values of 418 ms reported by Sy et al25 and 476
ms by Blich et al.26 Thus, there may be distinct clinical
features that distinguish between typical CPVT and scTdP
even among RyR2 mutation carriers. The potential dysfunc-
tion by respective mutation may be associated with the
phenotype of RyR2 mutation carriers.10Conclusion
scTdP should be considered as a diagnosis when the
etiology of aborted sudden cardiac death is unknown.
Despite unique ECG features at the onset of TdP, other
ECG ﬁndings speciﬁc to Brugada, long QT, or short QT
syndrome are all lacking. The diagnosis of scTdP is of
clinical and therapeutic importance, since some drugs or
even catheter ablation may be effective in reducing or
suppressing arrhythmic episodes.27,28 Among patients ini-
tially diagnosed as IVF and implanted with ICD, some
may have scTdP; therefore, an in-depth analysis of
arrhythmic events (especially their initiation) monitored
by ICD may allow further clariﬁcation of this speciﬁc IVFform and improve treatment. RyR2 loss-of-function muta-
tions may thus cause scTdP.
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